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The bioactive properties (antioxidant and antitumour activities, and hepatotoxicity) of 
the infusion and methanolic extracts of Chenopodium ambrosioides L., a plant 
commonly used in Portuguese folk medicine, were compared. The chemical 
composition in hydrophilic (sugars, organic acids and phenolic compounds) and 
lipophilic (fatty acids and tocopherols) fractions were determined. In general, the 
infusion revealed higher antioxidant activity, while the methanolic extract was the only 
one showing antitumour effects against colon, cervical and hepatocellular carcinoma 
cell lines. No toxicity in non-tumour cells was observed either for the infusion or the 
extract. The studied plant proved to be a good source of natural antioxidants and other 
bioactive compounds, which may have industrial use. As far as we know, this is the first 
detailed chemical characterization and bioactivity evaluation of C. ambrosioides 
methanolic extract and infusion. 
 






Oxidative stress is an imbalance between the generation of reactive oxygen species 
(ROS; which include unstable oxygen radicals such as superoxide radical and hydroxyl 
radical and non-radical molecules like hydrogen peroxide) and the body's antioxidant 
defence capacity, having an important role in normal cell functioning. When produced 
in excess ROS can have harmful effects, affecting cellular lipids, proteins and DNA, 
leading to their modification, and often destruction, and inhibiting their normal function 
(Valko et al., 2007; Rosenfeldt et al., 2013). Relevant diseases such as cancer, diabetes, 
cirrhosis, heart disease or dementia disorders, as well as aging process have been 
associated with the uncontrolled production of free radicals (Valko et al., 2007; 
Halliwell, 2012).  
Some plants traditionally used have medicinal properties with great potential for 
therapeutic applications in the treatment of some of the aforementioned diseases, since 
they are a natural source of bioactive compounds, including antioxidants, such as 
polyphenols, vitamins, carotenoids, unsaturated fatty acids and sugars, which can be 
useful for various applications, especially as food additives and in health promotion as 
ingredients in formulations of functional foods and nutraceuticals (Ramarathnam, 
Osawa, Ochi, & Kawakishi, 1995; Skerget et al., 2005).  
Chenopodium ambrosioides L. (Amaranthaceae; syn: Dysphania ambrosioides (L.) 
Mosyakin & Clemants) is an example of a plant formerly used in Portuguese traditional 
medicine, normally consumed as infusion of its dried leaves and flowering stems. It is 
an exotic plant from Central and South America that in former times was introduced by 
migrants from those countries. Nowadays the species has escaped to wild and can be 
occasionally found in pathways and near homegardens. It has diverse pharmacological 
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applications in the treatment of influenza, cold or gastrointestinal and respiratory 
ailments, as well as vomiting, antihelmintic, healing of skin ulceration caused by 
Leishmania species, anti-inflammatory and antitumor properties (Nascimento et al., 
2006; Cruz et al., 2007; Carvalho, 2010; Kamel, El-Emam, Mahmoud, Fouda, & 
Bayaumy, 2011).  
Studies on chemical characterization and bioactivity evaluation of this plant, 
particularly in the most consumed form (infusion) are scarce. The present work aims to 
characterize the chemical composition of C. ambrosioides in hydrophilic (sugars, 
organic acids and phenolic compounds) and lipophilic (fatty acids and tocopherols) 
molecules, as also some bioactive properties (antioxidant and antitumour activities, and 
hepatotoxicity) of its infusion and methanolic extract. 
 
2. Materials and methods 
2.1. Sample 
Chenopodium ambrosioides L. (Amaranthaceae) (English names: Epazote, wormseed, 
Jesuit's tea, Mexican tea; Local names: Té; chá-bravo; chá de Santa Marinha), also 
known as Dysphania ambrosioides (L.) Mosyakin & Clemants, (Amaranthaceae), used 
to be cultivated in homegardens in Bragança (Northeastern Portugal). Nowadays it is 
less frequent in gardens and there are some specimens growing wild nearby the local 
villages. However, if available, inflorescences and upper leaves are still wild gathered, 
dried and used as herbal infusions. The material was collected in Varge (Bragança) from 
different plants considering the species availability and local consumers’ criteria for 
medicinal use. A sample was made putting together all the material from several 
specimens.   
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Voucher specimens are deposited at the Herbarium of the Escola Superior Agrária de 
Bragança (BRESA). The samples were lyophilized (FreeZone 4.5, Labconco, Kansas 
City, MO, USA), reduced to a fine dried powder (20 mesh) and mixed to obtain a 
homogenate sample.  
 
2.2. Standards and Reagents 
Acetonitrile (99.9%), n-hexane (97%) and ethyl acetate (99.8%) were of HPLC grade 
from Fisher Scientific (Lisbon, Portugal). The fatty acids methyl ester (FAME) 
reference standard mixture 37 (standard 47885-U) was purchased from Sigma (St. 
Louis, MO, USA), as also were other individual fatty acid isomers and standards: L-
ascorbic acid, tocopherols (α-, β-, γ-, and δ-isoforms), sugars (D(-)-fructose, D(+)-
melezitose, D(+)-sucrose, D(+)-glucose, D(+)-trehalose and D(+)-raffinose 
pentahydrate), organic acids and trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid). Phenolic compounds were purchased from Extrasynthèse (Genay, 
France). Racemic tocol, 50 mg/mL, was purchased from Matreya (Pleasant Gap, PA, 
USA). 2,2-Diphenyl-1- picrylhydrazyl (DPPH) was obtained from Alfa Aesar (Ward 
Hill, MA, USA). Foetal bovine serum (FBS), L-glutamine, hank’s balanced salt solution 
(HBSS), trypsin-EDTA (ethylenediaminetetraacetic acid), penicillin/streptomycin 
solution (100 U/mL and 100 mg/mL, respectively), RPMI-1640 and DMEM media 
were from Hyclone (Logan, USA). Acetic acid, ellipticine, sulphorhodamine B (SRB), 
trypan blue, trichloroacetic acid (TCA) and Tris were from Sigma Chemical Co. (St 
Louis, MO, USA). Water was treated in a Milli-Q water purification system (TGI Pure 
Water Systems, Greenville, SC, USA). All other chemicals and solvents were of 




2.3. Evaluation of bioactive properties  
2.3.1. Samples preparation. The methanolic extract was obtained from the lyophilized 
plant material. The sample (1 g) was extracted by stirring with 25 mL of methanol (25 
ºC at 150 rpm) for 1 h and subsequently filtered through Whatman No. 4 paper. The 
residue was then extracted with 25 mL of methanol (25 ºC at 150 rpm) for 1 h. The 
combined methanolic extracts were evaporated at 40 ºC (rotary evaporator Büchi R-210, 
Flawil, Switzerland) to dryness.  
The infusion was also obtained from the lyophilized plant material. The sample (1 g) 
was added to 200 mL of boiling distilled water and left to stand at room temperature for 
5 min, and then filtered under reduced pressure. The obtained infusion was frozen and 
lyophilized. 
Methanolic extract and infusion were redissolved in i) methanol and water, respectively 
(final concentration 2.5 mg/mL) for antioxidant activity evaluation, or ii) water (final 
concentration 8 mg/mL) for antitumour activity evaluation. The final solutions were 
further diluted to different concentrations to be submitted to distinct bioactivity 
evaluation in in vitro assays. The results were expressed in i) EC50 values (sample 
concentration providing 50% of antioxidant activity or 0.5 of absorbance in the reducing 
power assay) for antioxidant activity, or ii) GI50 values (sample concentration that 
inhibited 50% of the net cell growth) for antitumour activity. Trolox and ellipticine 
were used as positive controls in antioxidant and antitumour activity evaluation assays, 
respectively. 
 
2.3.2. Antioxidant activity. DPPH radical-scavenging activity was evaluated by using an 
ELX800 microplate reader (Bio-Tek Instruments, Inc; Winooski, VT, USA), and 
calculated as a percentage of DPPH discolouration using the formula: [(ADPPH-
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AS)/ADPPH] × 100, where AS is the absorbance of the solution containing the sample at 
515 nm, and ADPPH is the absorbance of the DPPH solution. Reducing power was 
evaluated by the capacity to convert Fe3+ into Fe2+, measuring the absorbance at 690 nm 
in the microplate reader mentioned above. Inhibition of β-carotene bleaching was 
evaluated though the β-carotene/linoleate assay; the neutralization of linoleate free 
radicals avoids β-carotene bleaching, which is measured by the formula: β-carotene 
absorbance after 2h of assay/initial absorbance) × 100. Lipid peroxidation inhibition in 
porcine (Sus scrofa) brain homogenates was evaluated by the decrease in thiobarbituric 
acid reactive substances (TBARS); the colour intensity of the malondialdehyde-
thiobarbituric acid (MDA-TBA) was measured by its absorbance at 532 nm; the 
inhibition ratio (%) was calculated using the following formula: [(A - B)/A] × 100%, 
where A and B were the absorbance of the control and the sample solution, respectively 
(Pinela et al., 2012). 
 
2.3.3. Antitumour activity. Five human tumour cell lines were used: MCF-7 (breast 
adenocarcinoma), NCI-H460 (non-small cell lung cancer), HCT-15 (colon carcinoma), 
HeLa (cervical carcinoma) and HepG2 (hepatocellular carcinoma). Cells were routinely 
maintained as adherent cell cultures in RPMI-1640 medium containing 10% heat-
inactivated FBS (MCF-7, NCI-H460 and HCT-15) and 2 mM glutamine or in DMEM 
supplemented with 10% FBS, 2 mM glutamine, 100 U/mL penicillin and 100 mg/mL 
streptomycin (HeLa and HepG2 cells), at 37 ºC, in a humidified air incubator containing 
5% CO2. Each cell line was plated at an appropriate density (7.5 × 103 cells/well for 
MCF-7, NCI-H460 and HCT-15 or 1.0 × 104 cells/well for HeLa and HepG2) in 96-
well plates and allowed to attach for 24 h. Cells were then treated for 48 h with various 
extract concentrations. Following this incubation period, the adherent cells were fixed 
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by adding cold 10% trichloroacetic acid (TCA, 100 μL) and incubated for 60 min at 4 
ºC. Plates were then washed with deionised water and dried; sulphorhodamine B 
solution (0.1% in 1% acetic acid, 100 μL) was then added to each plate well and 
incubated for 30 min at room temperature. Unbound SRB was removed by washing 
with 1% acetic acid. Plates were air dried, the bound SRB was solubilised with 10 mM 
Tris (200 μL) and the absorbance was measured at 540 nm in the microplate reader 
mentioned above (Guimarães et al., 2013). 
 
2.3.4. Hepatotoxicity. A cell culture was prepared from a freshly harvested porcine liver 
obtained from a local slaughter house, and it was designed as PLP2. Briefly, the liver 
tissues were rinsed in hank’s balanced salt solution containing 100 U/mL penicillin, 100 
µg/mL streptomycin and divided into 1×1 mm3 explants. Some of these explants were 
placed in 25 cm2 tissue flasks in DMEM medium supplemented with 10% fetal bovine 
serum, 2 mM nonessential amino acids and 100 U/mL penicillin, 100 mg/mL 
streptomycin and incubated at 37 ºC with a humidified atmosphere containing 5% CO2. 
The medium was changed every two days. Cultivation of the cells was continued with 
direct monitoring every two to three days using a phase contrast microscope. Before 
confluence was reached, cells were subcultured and plated in 96-well plates at a density 
of 1.0×104 cells/well, and cultivated in DMEM medium with 10% FBS, 100 U/mL 
penicillin and 100 µg/mL streptomycin (Abreu et al., 2011). 
 
2.4. Chemical composition in hydrophilic compounds 
2.4.1. Sugars. Free sugars were determined by high performance liquid chromatography 
coupled to a refraction index detector (HPLC-RI). Dried sample powder (1.0 g) was 
spiked with the melezitose as internal standard (IS, 5 mg/mL), and was extracted with 
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40 mL of 80% aqueous ethanol at 80 ºC for 30 min. The resulting suspension was 
centrifuged (Centurion K24OR refrigerated centrifuge, West Sussex, UK) at 15,000g 
for 10 min. The supernatant was concentrated at 60 ºC under reduced pressure and 
defatted three times with 10 mL of ethyl ether, successively. After concentration at 40 
ºC, the solid residues were dissolved in water to a final volume of 5 mL and filtered 
through 0.2 µm nylon filters from Whatman (Pinela et al., 2012). The equipment of 
analysis consisted of an integrated system with a pump (Knauer, Smartline system 
1000, Brelin, Germany), degasser system (Smartline manager 5000), auto-sampler (AS-
2057 Jasco, Easton, MD) and an RI detector (Knauer Smartline 2300). Data were 
analysed using Clarity 2.4 Software (DataApex). The chromatographic separation was 
achieved with a Eurospher 100-5 NH2 column (4.6 × 250 mm, 5 mm, Knauer) operating 
at 30 ºC (7971 R Grace oven). The mobile phase was acetonitrile/deionized water, 
70:30 (v/v) at a flow rate of 1 mL/min. The compounds were identified by 
chromatographic comparisons with authentic standards. Quantification was performed 
using the internal standard method and sugar contents were further expressed in g per 
100 g of dry weight (dw). 
 
2.4.2. Organic acids extraction and analysis. Organic acids were determined using 
ultra-fast liquid chromatography coupled to a photodiode array detector (UFLC-PDA). 
Samples (~2 g) were extracted by stirring with 25 mL of meta-phosphoric acid (25ºC at 
150 rpm) for 45 min and subsequently filtered through Whatman No. 4 paper. Before 
analysis, the sample was filtered through 0.2 µm nylon filters (Barros, Pereira, Ferreira, 
2013). The analysis was performed using a Shimadzu 20A series UFLC (Shimadzu 
Corporation, Kyoto, Japan). Separation was achieved on a SphereClone (Phenomenex, 
Torrance, CA, USA) reverse phase C18 column (5 µm, 250 mm × 4.6 mm i.d.) 
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thermostatted at 35 ºC. The elution was performed with sulphuric acid (3.6 mM) using a 
flow rate of 0.8 mL/min. Detection was carried out in a PDA, using 215 and 245 nm 
(for ascorbic acid) as preferred wavelengths. The organic acids found were quantified 
by comparison of the area of their peaks recorded at 215 and 245 nm with calibration 
curves obtained from commercial standards of each compound: ascorbic acid 
(y=8E+07x+55079; R2=1); citric (y=1E+06x+4170.6; R2=1); fumaric acid 
(y=172760x+52193; R2=0.999); malic acid (y=952269x+17803; R2=1); oxalic acid 
(y=1E+07x+96178; R2=0.999); quinic acid (y=601768x+8853.2; R2=1). The results 
were expressed in g per 100 g of dry weight (dw).  
 
2.4.3. Phenolic compounds extraction and analysis. The previously described 
methanolic extract and infusion were dissolved in water:methanol (80:20, v/v) and 
water, respectively (final concentration 1 mg/mL) and analysed using a Hewlett-
Packard 1100 chromatograph (Hewlett-Packard 1100, Agilent Technologies, Santa 
Clara, CA, US) with a quaternary pump and a diode array detector (DAD) coupled to an 
HP Chem Station (rev. A.05.04) data-processing station. A Waters Spherisorb S3 ODS-
2 C18, 3 µm (4.6 mm × 150 mm) column thermostatted at 35 °C was used. The solvents 
used were: (A) 0.1% formic acid in water, (B) acetonitrile. The elution gradient 
established was isocratic 15% for 5 min, 15% B to 20% B over 5 min, 20-25% B over 
10 min, 25-35% B over 10 min, 35-50% for 10 min, and re-equilibration of the column, 
using a flow rate of 0.5 mL/min. Double online detection was carried out in the DAD 
using 280 nm and 370 nm as preferred wavelengths and in a mass spectrometer (MS) 
connected to HPLC system via the DAD cell outlet. 
MS detection was performed in an API 3200 Qtrap (Applied Biosystems, Darmstadt, 
Germany) equipped with an ESI source and a triple quadrupole-ion trap mass analyzer 
11 
 
that was controlled by the Analyst 5.1 software. Zero grade air served as the nebulizer 
gas (30 psi) and turbo gas for solvent drying (400 ºC, 40 psi). Nitrogen served as the 
curtain (20 psi) and collision gas (medium). The quadrupols were set at unit resolution. 
The ion spray voltage was set at -4500V in the negative mode. The MS detector was 
programmed for recording in two consecutive modes: Enhanced MS (EMS) and 
enhanced product ion (EPI) analysis. EMS was employed to show full scan spectra, so 
as to obtain an overview of all of the ions in sample. Settings used were: declustering 
potential (DP) -450 V, entrance potential (EP) -6 V, collision energy (CE) -10V. EPI 
mode was performed in order to obtain the fragmentation pattern of the parent ion(s) in 
the previous scan using the following parameters: DP -50 V, EP -6 V, CE -25V, and 
collision energy spread (CES) 0 V. Spectra were recorded in negative ion mode between 
m/z 100 and 1000. 
The phenolic compounds present in the samples were characterised according to their 
UV and mass spectra and retention times compared with standards when available. For 
the quantitative analysis of phenolic compounds, a 5-level calibration curve was 
obtained by injection of known concentrations (2.5-100 µg/mL) of different standards 
compounds: p-coumaric (y=884.6x+184.49; R2=0.999); ferulic acid (y=505.97x-64.578; 
R2=0.999); isorahmetin-3-O-rutinoside (y=327.42x+313.78; R2=0.999); luteolin-6-C-
glucoside (y=508.54x-152.82; R2=0.997); luteolin-7-O-glucoside (y=80.829x-21.291; 
R2=0.999); kaempferol-3-O-glucoside (y=288.55x-4.05; R2=1); kaempferol-3-O-
rutinoside (y=239.16x-10.587; R2=1); quercetin-3-O-glucoside (y=253.52x-11.615; 
R2=0.999) and quercetin-3-O-rutinoside (y=281.98x-0.3459; R2=1). The results were 
expressed in mg per 100 g of dry weight (dw). 
 
2.5. Chemical composition in lypophilic compounds 
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2.5.1. Fatty acids. Fatty acids were determined by gas-liquid chromatography with 
flame ionization detection (GC-FID)/capillary column, after trans-esterification 
procedure. Fatty acids (obtained after Soxhlet extraction) were methylated with 5 mL of 
methanol:sulphuric acid:toluene 2:1:1 (v:v:v), during at least 12 h in a bath at 50 ºC and 
160 rpm; then 3 mL of deionised water were added, to obtain phase separation; the 
FAME were recovered with 3 ml of diethyl ether by shaking in vortex , and the upper 
phase was passed through a micro-column of sodium sulphate anhydrous, in order to 
eliminate the water; the sample was recovered in a vial with Teflon, and before injection 
the sample was filtered with 0.2 µm nylon filter from Whatman (Pinela et al., 2012). 
The analysis was carried out with a DANI model GC 1000 instrument equipped with a 
split/splitless injector, a flame ionization detector (FID at 260 ºC) and a Macherey–
Nagel (Düren, Germany) column (50% cyanopropyl-methyl-50% 
phenylmethylpolysiloxane, 30 m × 0.32 mm i.d. × 0.25 μm df). The oven temperature 
program was as follows: the initial temperature of the column was 50 ºC, held for 2 min, 
then a 30 ºC/min ramp to 125 ºC, 5 ºC/min ramp to 160 ºC, 20 ºC/ min ramp to 180 ºC, 
3 ºC/min ramp to 200 ºC, 20 ºC/min ramp to 220 ºC and held for 15 min. The carrier gas 
(hydrogen) flow-rate was 4.0 mL/min (0.61 bar), measured at 50 ºC. Split injection 
(1:40) was carried out at 250 ºC. Fatty acid identification was made by comparing the 
relative retention times of FAME peaks from samples with standards. The results were 
recorded and processed using the CSW 1.7 Software (DataApex 1.7) and expressed in 
relative percentage of each fatty acid. 
 
2.5.2. Tocopherols. Tocopherols were determined by HPLC (equipment described 
above), and a fluorescence detector (FP-2020; Jasco). BHT solution in hexane (10 
mg/mL; 100 µL) and IS solution in hexane (tocol; 50 µg/mL; 400 µL) were added to the 
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sample prior to the extraction procedure. The samples (~500 mg) were homogenized 
with methanol (4 mL) by vortex mixing (1 min). Subsequently, hexane (4 mL) was 
added and again vortex mixed for 1 min. After that, saturated NaCl aqueous solution (2 
mL) was added, the mixture was homogenized (1 min), centrifuged (5 min, 4000g) and 
the clear upper layer was carefully transferred to a vial. The sample was re-extracted 
twice with hexane. The combined extracts were taken to dryness under a nitrogen 
stream, redissolved in 2 mL of n-hexane, dehydrated with anhydrous sodium sulphate, 
filtered through 0.2 µm nylon filters from Whatman, transferred into a dark injection 
vial prior to the analysis (Pinela et al., 2012). The fluorescence detector was 
programmed for excitation at 290 nm and emission at 330 nm. The chromatographic 
separation was achieved with a Polyamide II (250 mm × 4.6 mm i.d.) normal-phase 
column from YMC Waters operating at 30 ºC. The mobile phase used was a mixture of 
n-hexane and ethyl acetate (70:30, v/v) at a flow rate of 1 mL/min, and the injection 
volume was 20 µL. The compounds were identified by chromatographic comparisons 
with authentic standards. Quantification was based on calibration curves obtained from 
commercial standards of each compound using the IS methodology. The results were 
expressed in mg per 100 g of dry weight (dw).  
 
2.6. Statistical analysis 
Three samples were used and all the assays were carried out in triplicate. The results are 
expressed as mean values and standard deviation (SD). The results were analyzed using 
one-way analysis of variance (ANOVA) followed by Tukey’s HSD Test with α = 0.05. 
This treatment was carried out using SPSS v. 18.0 program.  
 
3. Results and Discussion 
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3.1. Evaluation of bioactive properties  
The results obtained in the evaluation of the bioactive properties (antioxidant and 
antitumour activities, and hepatotoxicity) of the infusion and the methanolic extract of 
C. ambrosioides are given in Table 1. The infusion gave higher DPPH scavenging 
activity and β-carotene bleaching and TBARS inhibitions than the methanolic extract. 
The latter revealed higher reducing power. The essential oil extracted from the leaves of 
C. ambrosioides (Kumar, Kumar, Dubey, & Tripathi, 2007) was also reported to show 
powerful antioxidant activity. To the best of our knowledge, no reports are available on 
the infusion or methanolic extract of the aforementioned plant.  
The effects of C. ambrosioides methanolic extract and infusion on the growth of five 
human tumour cell lines (MCF-7, NCI-H460, HCT-15, HeLa and HepG2), represented 
as the concentrations that caused 50% of cell growth inhibition (GI50), are also 
summarized in Table 1. The infusion of C. ambrosioides did not show any antitumour 
potential; however, the methanolic extract presented some activity on HCT-15, HeLa 
and HepG2 cell lines. It should be highlighted that no hepatotoxicity in non-tumour 
cells was observed for any of the samples (GI50 > 400 µg/mL). Trolox and ellipticine 
were used as positive controls of antioxidant and antitumour activities evaluation 
assays, respectively, but comparison with the samples should be avoided, because they 
are individual compounds and not mixtures.  
 
3.2. Chemical composition in hydrophilic compounds 
The chemical composition of the samples in sugars and organic acids was also analyzed 
and the results are shown in Table 2. The sugars found were fructose, glucose, sucrose 
and trehalose, sucrose being the most abundant.  
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Oxalic, quinic, malic, ascorbic, citric and fumaric acids were also identified and 
quantified (Table 2), being oxalic acid the most abundant organic acid. Some organic 
acids (e.g., citric acid) have been reported as having antioxidant capacity (Hraš, 
Halodin, Knez, & Bauman, 2000).  
Phenolic compounds found in C. ambrosioides are presented in Table 3 and Figure 1. 
Thirty-five compounds were detected, eight of which were phenolic acid derivatives 
(hydroxycinnamic acid derivatives). Among them, five compounds (peaks 1-3, 5 and 9) 
were p-coumaric acid derivatives identified according to their UV spectra and 
pseudomolecular ion. Peak 9 was identified as trans p-coumaric acid by comparison of 
its UV spectrum (λmax 312 nm) and retention time with a commercial standard. Peak 1 
was identified as a p-coumaroyl pentoside acid according to its pseudomolecular [M-H]- 
ion (m/z at 295) and the release of fragments at m/z 163 [p-coumaric acid-H]- (-132 mu, 
pentose) and m/z 119 (loss of 132+44 mu, pentose + CO2). Peaks 2, 3 and 5 presented 
pseudomolecular ions [M-H]- at m/z 287 and 387 releasing the same fragment ions at 
m/z 163 and 119, which allowed assigning them to p-coumaroyl acid derivatives, 
although their precise identities could not be established. The other three phenolic acid 
derivatives were identified as ferulic acid derivatives based on the observation of the 
ions at m/z 193 ([ferulic acid-H]-) and 149 ([ferulic acid-CO2-H]-). Peak 14 could be 
identified as free ferulic acid by comparison of its UV spectrum (λmax 326 nm) and 
retention time with a commercial standard. Peak 4 was associated to a feruloyl 
pentoside acid based on its molecular ion fragmentation pattern similar to peak 1, 
whereas no precise identity could be established for peak 6. 
 
The remaining phenolic compounds corresponded to flavone and flavonol derivatives, 
most of them derived from quercetin (λmax around 354 nm and MS2 fragment at m/z 301; 
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12 compounds) and kaempferol (λmax around 346 nm and MS2 fragment at m/z 285; 11 
compounds) (Table 3). Quercetin 3-O-rutinoside (peak 17), quercetin 3-O-glucoside 
(peak 21) and kaempferol 3-O-rutinoside (peak 24) were positively identified according 
to their retention, mass and UV-vis characteristics by comparison with commercial 
standards.  
Peak 10 ([M-H]- at m/z 609) could be interpreted as a quercetin O-diglycosides in which 
each of the sugar moieties are located at different positions on the aglycone, owing to 
the observation of fragments derived from the loss of each sugar residue. However, it 
might also be rationalised as a quercetin O-rhamnosyl-glucoside, in which the fragment 
at m/z 447 would correspond to the loss of the terminal glucose of the dissacharide, 
whereas that at m/z 463 might be rationalised as produced by an internal rearrangement 
in the sugar moieties following the loss of the internal dehydrated glucose/pentose and 
further linkage of the terminal rhamnose to the aglycone (Ma, Cuyckens, Heuvel, & 
Claeys, 2001). In that case, the greater abundance of the Y0 ion (m/z at 301; aglycone) 
than Y1 ion (m/z at 447; breakdown of the interglycosidic linkage) might support the 
existence of a 1,2 interglycosidic linkage (Cuyckens, Rozenberg, Hoffmann, & Claeys, 
2001), which allow the identification of peak 10 as quercetin 3-O-neohesperidose.  
Peaks 15 and 20, both with a pseudo molecular ion [M-H]- at m/z 579 releasing 
fragments at m/z 447 (-132 mu; pentiosyl residue) and 301 (-132-146 mu; loss of 
pentosyl+ rhamnosyl residues), could be assigned as quercetin O-rhamnosyl-pentosides 
in which the pentose is the terminal unit owing to the lack of a fragment at m/z 433, 
which should result from the loss of the rhamnose residue if both sugars were located at 
different positions on the aglycone. The observation that Y0 > Y1 ion in the case of peak 
20 might point to a 1,2 interglycosidic linkage, whereas a 1,6 linkage might exist in 
peak 15 where Y1 > Y0 (Cuyckens et al., 2001). Peaks 29 and 30, both possessing a 
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pseudo molecular ion [M-H]- at m/z 623 and releasing fragments at m/z 447 (-176 mu; 
loss of a glucuronyl residue) and 301 (-176-146 mu; loss of glucuronyl+rhamnosyl 
residues) should correspond to quercetin O-rhamnosyl-glucuronides. Furthermore, as 
mentioned above, in peak 30 a 1,2 interglycosidic linkage could be observation  (Y0 > 
Y1 ), whereas a 1,6 linkage might exist in peak 29 (Y1 > Y0).  Peak 34 can be assigned to 
an acetyl derivative of peak 30 owing to its pseudomolecular ion ([M-H]- at m/z 665) 42 
mu higher than that peak.  
The pseudomolecular ion of peak 19 ([M-H]- at m/z 593) is coherent with a quercetin 
derivative bearing two rhamnosyl residues. In principle, it can be supposed that each 
sugar is located at different positions on the aglycone as suggested by the formation of a 
fragment ion at m/z 447 from the loss of one of the rhamnosyl moieties, although the 
possibility that they constituted a disaccharide cannot be disregarded, either. 
Peak 11 ([M-H]- at m/z 741) can be assigned to a quercetin derivative bearing pentosyl, 
rhamnosyl and hexosyl residues, based on the loss of 440 u (132+146+162 u) to yield 
the corresponding aglycone (m/z at 301, quercetin). The fact that the three moieties were 
lost simultaneously suggested that they might constitute a trisaccharide O-linked to the 
aglycone. Similarly, peak 12 would be associated to a quercetin O-disaccharide 
consisting of a pentose and a hexose. 
Peak 8 ([M-H]- at m/z 755) would correspond to a quercetin derivative possessing two 
rhamnosyl and one glucosyl moieties. The observation of a fragment at m/z 609 from 
the lost of a rhamnosyl residue (-146 mu) points to this sugar is located on the aglycone 
in a position different to the other two sugars that should constitute a disaccharide. The 
presence of quercetin 3-O-rutinoside (peak 17) as majority flavonoid in the plant might 
suggest that peak 8 could be quercetin 3-O-rutinoside-O-rhamnoside. 
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Similar reasoning as for the quercetin derivatives has been applied for assigning the 
identities of kaempferol (peaks 13, 16, 18, 22, 23, 25, 26, 31, 32 and 35) and 
isorhamnetin derivatives (peaks 27, 28 and 33), as indicated in Table 3. 
Finally, peak 7 ([M-H]- at m/z 579) was assigned to a flavone, luteolin C-hexoside-O-
pentoside, based on its fragmentation. Thus, the ion at m/z 447 could be interpreted as 
the loss of the pentosyl moiety (-132 mu) and a fragment of 120 mu characteristic of the 
cleavage of pyran ring in the more strongly linked C-hexoses, whereas the ion at m/z 
417 might correspond to the loss of the hexosyl moiety and a fragment of 30 mu 
resulting from CH2O functional group of the hexose, also observed in the case of C-
hexoses (Abad-Garcia, Garmon-Lobato, Berrueta, Gallo, & Vicente, 2008). The 
fragments ions at m/z 447 and 285 would correspond to the respective losses of the 
pentosyl and hexosyl moieties, respectively.  
Flavonoids were the major phenolic compounds present in this sample (768 mg/100 g 
dw), being quercetin (46.98%) and kaempferol derivatives (45.91%) the most abundant. 
Quercetin 3-O-rutinoside was the compound found in the highest amount (205 mg/100 
g dw, peak 17), followed by kaempferol dirhamnoside-O-pentoside (96 mg/100 g dw, 
peak 25). Phenolic acids were 6.58% of the total phenolic compounds in this sample 
and trans p-coumaric acid was the most abundant one (25.65 mg/100 g dw, peak 9). 
Herbal infusions are frequently used in traditional medicine due to their beneficial 
activities and among their constituents, special relevance has been given to phenolic 
compounds, which often exhibit high antioxidant capacity being able to counteract 
oxidative stress (Mejía, Songa, Hecka, Vinicio, & Ramírez-Mares, 2010; Pereira, 
Marcias, Perez, Marin & Cardoso, 2013). They act as antioxidants through various 
mechanisms, including hydrogen donating reactions, metal chelation, and up-regulation 
or protection of antioxidant defenses (e.g. intracellular glutathione levels) (Pereira et al., 
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2013). In particular, C. ambrosioides infusion is a rich source of diverse polyphenols 
that could contribute to the mentioned activity. 
 
3.3. Chemical composition in lipophilic compounds 
The results of lipophilic compounds (fatty acids and tocopherols) are shown in Table 4. 
Up to 26 fatty acids were identified and quantified. Polyunsaturated fatty acids (PUFA) 
predominated over saturated fatty acids (SFA) and monounsaturated fatty acids 
(MUFA). α-Linolenic (C18:3n3; 48.54%) and linoleic (C18:2n6; 19.23%) acids 
contribute to the high levels of PUFA observed (68.44%). Linoleic acid is the most 
prominent PUFA in the Western diet and previous studies showed health benefits under 
the prevention of cancer diseases (Whelan, 2008). 
α-Tocopherol was, by far, the most abundant tocopherol in C. ambrosioides (199.37 
mg/100 g dw from a total tocopherols amount of 202.34 mg/100 g dw; Table 4). 
Tocopherols are very important natural antioxidants in plant foods, especially those that 
are rich in PUFA. Their effectiveness as antioxidants depends not only on their 
reactivity against harmful radicals, but also the relatively stable nature of his radical due 
to relocation of the unpaired electron on the ring cromanol (Kagan et al., 2003).   
 
Overall, C. ambrosioides infusion revealed, in general, higher antioxidant activity, 
while the methanolic extract was the only one showing antitumour effects against colon, 
cervical and hepatocellular carcinoma cell lines. Neither the infusion nor the extract 
reveal toxicity for non-tumour cells. Bioactive compounds such as some sugars and 
organic acids, phenolic compounds, unsaturated fatty acids and tocopherols were 
identified and quantified in C. ambrosioides. As far as we know, this is the first detailed 
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chemical characterization of C. ambrosioides and bioactivity evaluation of its 
methanolic extract and infusion. 
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Table 1. Bioactive properties of the methanolic extract and infusion of wild 
Chenopodium ambrosioides. 
 
 Methanolic extract Infusion Positive control* 
Antioxidant activity    
DPPH scavenging activity 
(EC50, mg/mL) 
0.62 ± 0.08a 0.49 ± 0.02b 0.04 ± 0.00 
Reducing power  
(EC50, mg/mL) 
0.47 ± 0.03b 0.65 ± 0.01a 0.03 ± 0.00 
β-carotene bleaching inhibition  
(EC50, mg/mL) 
2.53 ± 0.04a 2.32 ± 0.37b 0.003 ± 0.00 
TBARS inhibition  
(EC50, mg/mL)  
0.70 ± 0.29a 0.25 ± 0.01b 0.004 ± 0.00 
Antitumour activity    
MCF-7 (breast carcinoma) 
(GI50, µg/mL) 
>400 >400 0.91±0.04 
NCI-H460 (non-small cell lung cancer) 
(GI50, µg/mL) 
>400 >400 1.42±0.00 
HCT-15 (colon carcinoma) 
(GI50, µg/mL) 
318.75±13.21 >400 1.91±0.06 
HeLa (cervical carcinoma) 
(GI50, µg/mL) 
264.17±10.57 >400 1.14±0.21 
HepG2 (hepatocellular carcinoma) 
(GI50, µg/mL) 
287.43±21.99 >400 3.22±0.67 
Hepatotoxicity    
PLP2 (GI50, µg/mL) >400 >400 2.06±0.03 
 
*Trolox and ellipticine for antioxidant and antitumour activity assays, respectively. EC50 values 
correspond to the sample concentration achieving 50% of antioxidant activity or 0.5 of absorbance in 
reducing power assay. GI50 values correspond to the sample concentration achieving 50% of growth 
inhibition in human tumour cell lines or in liver primary culture PLP2. In each row different letters mean 
significant differences (p<0.05). 
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Table 2. Chemical composition in hydrophilic compounds- sugars and organic acids- of 
wild Chenopodium ambrosioides. 
 
Free sugars g/100 g dw Organic acids g/100 g dw 
Fructose  0.24 ± 0.01 Oxalic acid 5.64 ± 0.30 
Glucose  0.46 ± 0.01 Quinic acid 0.97 ± 0.14 
Sucrose  1.43 ± 0.12 Malic acid 0.67 ± 0.06 
Trehalose  0.91 ± 0.03 Ascorbic acid 0.02 ± 0.00 
Total sugars  3.04 ± 0.07 Citric acid 0.26 ± 0.01 
  Fumaric acid 0.02 ± 0.00 
  Total organic acids   7.58 ± 0.52  
 




Table 3. Retention time (Rt), wavelengths of maximum absorption in the UV-vis region (λmax), pseudomolecular and MS2 fragment ions (in 
brackets, relative abundances), identification and quantification of phenolic compounds in wild C. ambrosiodes. 
Peak Rt (min) 
λmax 
 (nm) 






(mg/100 g dw) 
1 6.8 310 295 163(100),119(60) p-Coumaroyl pentoside acid 3.53 ± 0.50 
2 7.1 314 278 163(6),119(13) p-Coumaroyl acid derivative 9.75 ± 0.44 
3 7.5 328 387 387(100)207(25),163(50),119(37) p-Coumaroyl acid derivative 1.41 ± 0.09 
4 8.2 328 325 193(100),149(38) Feruloyl pentoside acid 2.58 ± 0.27 
5 8.8 308 278 163(6),119(13) p-Coumaroyl acid derivative 1.21 ± 0.15 
6 14.8 326 473 267(27),193(100) Ferulic acid derivative 3.51 ± 0.14 
7 15.7 332 579 447(15),417(7),327(7),285(100) Luteolin C-hexoside-O-pentoside 2.27 ± 0.09 
8 15.9 354 755 609(2),301(100) Quercetin 3-O-rutinoside-(1→2)-O-rhamnoside 15.23 ± 0.41 
9 16.4 312 163 119(100) trans p-Coumaric acid 25.65 ± 0.77 
10 16.9 356 609 463(30),447(33),301(36) Quercetin 3-O-neohesperide 7.19 ± 0.32 
11 17.2 354 741 301(100) Quercetin O-pentosyl-rhamnosyl-hexoside 27.60 ± 0.31 
12 17.6 356 595 301(100) Quercetin O-pentosyl-hexoside 3.55 ± 0.46 
13 18.1 348 739 285(100) Kaempferol O-dirhamnosyl-hexoside 20.38 ± 0.74 
14 18.3 326 193 149(17),135(100) Ferulic acid 6.43 ± 0.53 
15 18.6 354 579 447(100),301(33) Quercetin O-rhamnosyl-pentoside 8.06 ± 0.87 
16 19.0 348 739 593(83),431(17),285(67) Kaempferol dirhamnoside-O-hexoside 4.80 ± 0.49 
17 19.4 354 609 301(100) Quercetin-3-O-rutinoside 204.95 ± 6.39 
18 19.8 346 725 285(100) Kaempferol O-pentosyl-rhamnosyl-hexoside 31.42 ± 1.36 





















dw- dry weight; tr- traces
20 20.4 354 579 447(45),301(100) Quercetin O-rhamnosyl-pentoside 1.22 ± 0.03 
21 20.8 350 463 301(100) Quercetin 3-O-glucoside 12.91 ± 0.80 
22 21.5 348 563 431(53),285(100) Kaempferol O-rhamnosyl-pentoside 4.93 ± 0.08 
23 22.4 344 739 593(24),431(24),285(100) Kaempferol dirhamnoside-O-hexoside 11.31 ± 0.44 
24 23.1 348 593 285(100) Kaempferol 3-O-rutinoside 74.82 ± 2.29 
25 23.5 342 709 563(25),431(63),285(100) Kaempferol dirhamnoside-O-pentoside 95.89 ± 1.64 
26 23.9 344 563 431(47),285(100) Kaempferol O-rhamnosyl-pentoside 36.15 ± 1.40 
27 24.6 350 607 461(50),315(100) Isorhamnetin dirhamnoside tr  
28 25.1 352 593 461(80),315(100) Isorhamnetin O-rhamnosyl-pentoside 1.60 ± 0.09 
29 26.0 352 623 447(50),301(43) Quercetin O-rhamnosyl-glucuronide 2.48 ± 0.04 
30 26.6 352 623 447(33),301(51) Quercetin O-rhamnosyl-glucuronide 33.99 ± 0.28 
31 29.6 344 607 459(30),431(20),285(50) Kaempferol O-rhamnosyl-glucuronide 6.54 ± 0.28 
32 30.5 346 607 431(100),285(86) Kaempferol O-rhamnosyl-glucuronide 56.08 ± 0.35 
33 31.2 350 637 461(100),315(87) Isorhamnetin O-rhamnosyl-glucuronide 0.50 ± 0.00 
34 31.7 352 665 623(14),447(35),301(18) Quercetin (acyl)glucuronide-O-rhamnoside 12.53 ± 0.56 
35 35.1 344 649 607(6),431(42),285(31) Kaempferol (acyl)glucuronide-O-rhamnoside 35.26 ± 1.43 
     Phenolic acids 54.07 ± 1.55 
     Flavonoids 768.27 ± 10.70 
     Phenolic compounds 822.33 ± 12.25 
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dw- dry weight. SFA- Saturated fatty acids; MUFA- Monounsaturated fatty acids; PUFA- 
Polyunsaturated fatty acids.   
 
Fatty acids Relative percentage Fatty acids Relative percentage 
C6:0 0.10 ± 0.01 C18:3n3 48.54 ± 0.13 
C8:0 0.49 ± 0.02 C20:0 0.83 ± 0.00 
C10:0 0.34 ± 0.01 C20:1 0.19 ± 0.01 
C12:0 0.17 ± 0.03 C20:2 0.17 ± 0.03 
C13:0 0.41 ± 0.01 C20:3n6 0.12 ± 0.01 
C14:0 0.48 ± 0.02 C20:4n6 0.04 ± 0.01 
C14:1 0.47 ± 0.05 C20:3n3+C21:0 0.29 ± 0.01 
C15:0 0.44 ± 0.02 C20:5n3 0.03 ± 0.01 
C16:0 14.16 ± 0.03 C22:0 1.85 ± 0.05 
C16:1 0.14 ± 0.03 C22:2 0.01 ± 0.00 
C17:0 0.32 ± 0.01 C23:0 0.21 ± 0.00 
C18:0 1.57 ± 0.08 C24:0 2.52 ± 0.09 
C18:1n9 6.90 ± 0.12 SFA 23.87 ± 0.08 
C18:2n6 19.23 ± 0.12 MUFA 7.69 ± 0.16 
  PUFA 68.44 ± 0.08 
Tocopherols  mg/100 g dw   
α-tocopherol 199.37 ± 4.92   
β-tocopherol 0.56 ± 0.00   
γ-tocopherol 2.28 ± 0.10   
δ-tocopherol 0.13 ± 0.00   




















Figure 1. HPLC phenolic profile of Chenopodium ambrosiodes, obtained at 370 nm (A) and 280 
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